DIMA Biotech

DIMA Biotech is a biotechnology company specializing in the discovery and development of therapeutic antibodies, particularly focusing on challenging targets such as G-protein coupled receptors (GPCRs) and multi-pass transmembrane proteins. The company utilizes its proprietary DimAb recombinant monoclonal antibody platform and DiLibrary phage display technology to generate high-affinity, functional lead antibodies. DIMA Biotech offers an extensive catalog of off-the-shelf lead antibodies and recombinant proteins, alongside custom services including antibody engineering, cell line development, and protein expression. By providing validated lead candidates and comprehensive discovery services, the company aims to significantly reduce the time and risk associated with early-stage drug development for its global pharmaceutical and biotech clients.